EQ vs VRTX · rev $41.1M vs P/E 30, rev $12.00B
Equillium Inc (EQ) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Equillium Inc (EQ) is a biotechnology company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported EQ revenue for 2024-12-31 was $41.1M. Net income was -$8.1M. Revenue was up 13.9% from 2023-12-31 to 2024-12-31. EQ currently screens at market cap $189.0M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
EQ currently screens at market cap $189.0M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the EQ and VRTX stock pages for the full models.
Not investment advice.